Biotechnology News and Research

RSS

Isogenica, NovaBiotics to accelerate the development of peptide anti-infective technology

Isogenica Ltd, today announced that it has entered into a collaboration agreement with NovaBiotics, a leading clinical-stage biotechnology company to fast-track the development of NovaBiotic's platform peptide anti-infective technology.

6 Oct 2010

Apricus Bio raises over $9.3 million in securities offering

Apricus Biosciences, backed by a revenue generating CRO business and seeking to leverage its multi-route NexACT® drug delivery technology and internal pipeline through out-licensing partnerships, today announced that the Company has closed its previously announced securities offering, raising over $9.3 million in gross proceeds. Apricus Bio intends to use the proceeds from this offering for product and technology development and general corporate purposes. Dawson James Securities acted as the exclusive placement agent for the offering.

5 Oct 2010

TMNG Global and Scientia Advisors partner to offer strategic consulting services for home health sector

TMNG Global a leading provider of professional services to the global communications, digital media, technology, and financial services industries, and Scientia Advisors, a global management consulting firm specializing in healthcare, life science, nutrition and biotechnology, today announced a partnership to offer strategic consulting services for the emerging home health sector.

5 Oct 2010

Galapagos honored with 2010 EUROPEAN BIOTECHNICA AWARD

The Belgian biotech company Galapagos has won the 2010 EUROPEAN BIOTECHNICA AWARD. Galapagos thus secures the lion's share of the prize money totalling 75,000 euros, which is offered every year in the competition staged by Deutsche Messe AG and its partners. The award celebrates innovative European companies from the biotechnology sector and the life sciences.

5 Oct 2010

ImmunoCellular Therapeutics to present ICT-107 clinical data at World Stem Cell Summit

ImmunoCellular Therapeutics, a biotechnology company focused on the development of novel immune-based cancer therapies, today announced that the company's clinical data from ICT-107 will be featured in two oral sessions at the World Stem Cell Summit, which is being held October 4-6 in Detroit, MI.

5 Oct 2010

EUCODIS Bioscience, evocatal enter alliance to market industrial enzyme products

Industrial biotech companies EUCODIS Bioscience and evocatal today announced the formation of an alliance to jointly market the companies' industrial enzyme products, including alcohol dehydrogenases, lipases, and other enzymes.

5 Oct 2010

Genzyme shareholders urged not to take action on unsolicited tender offer from Sanofi-Aventis

Genzyme Corp. said today that its board of directors urged shareholders to take no action on an unsolicited tender offer from Sanofi-Aventis to acquire all outstanding common shares of Genzyme for $69 per share.

5 Oct 2010

Bio-Matrix Scientific Group in discussions to develop adult stem cell repositories

Bio-Matrix Scientific Group Inc. announced today the company has entered into discussions with several organizations regarding the establishment of adult stem cell repositories at the company's 15,000 sq. ft. facility.

5 Oct 2010

PAREXEL expands presence in Japan with new office in Nagoya

PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced that the Company has opened a new office in Nagoya, Japan to support a growing demand for a broad range of clinical development and regulatory consulting capabilities in the country and throughout the Asia/Pacific region.

From Parexel 5 Oct 2010

Asterand to supply clinically annotated human biospecimens for The Cancer Genome Atlas project

Asterand plc, a leading provider of human tissue and human tissue-based services to pharmaceutical and biotechnology companies engaged in drug discovery research announced today that it has been awarded a 5-year, up to $24.3 million contract with the National Cancer Institute (NCI) to supply clinically annotated human biospecimens for The Cancer Genome Atlas (TCGA) project.

5 Oct 2010

Researchers call for sustained funding to move HIV vaccine R&D ahead

At the AIDS Vaccine 2010 conference last week in Atlanta, researchers emphasized the need for sustained funding for vaccine research and development in order to further progress toward an HIV vaccine, SciDev.Net reports.

5 Oct 2010

Evotec enters multiple target drug discovery collaboration with Shionogi

Evotec AG today announced that it has entered into a multiple target drug discovery collaboration with Shionogi & Co Ltd., to identify small molecule modulators of various protein-protein interaction targets.

5 Oct 2010

Amgen announces PRIME '203' and '181' Phase 3 trial results

Amgen today announced that results from the PRIME '203' and '181' pivotal Phase 3 trials evaluating Vectibix (panitumumab) in combination with chemotherapy (FOLFOX or FOLFIRI) as a first and second-line treatment for metastatic colorectal cancer (mCRC), respectively, were published online in the Journal of Clinical Oncology.

5 Oct 2010

Seattle Genetics to present SGN-75 phase I data at ESMO Congress

Seattle Genetics, Inc. today announced that preliminary data from a phase I study of SGN-75 in relapsed and refractory non-Hodgkin lymphoma and metastatic renal cell carcinoma will be presented during a poster session at the 35th European Society for Medical Oncology (ESMO) Congress being held October 8-12, 2010 in Milan, Italy.

5 Oct 2010

CHI submits comments to FDA CDRH 510(k) Working Group Preliminary Report and Recommendations

California Healthcare Institute today submitted formal comments to the U.S. Food and Drug Administration (FDA) regarding the Center for Devices and Radiological Health 510(k) Working Group Preliminary Report and Recommendations, which could transform the 510(k) regulatory process for new medical devices, greatly affecting innovation and public health in California. CHI is a non-profit public policy research organization, representing leading California academic institutions, biotechnology, medical device, diagnostics and pharmaceutical firms.

5 Oct 2010

Terminal metastatic cancer effectively treated in mice

Terminal metastatic cancer - the presently untreatable cause of the great majority of all cancer deaths - has now been effectively treated in three common fatal cancers in mice, announced Genomic Systems, citing research published online today in the Proceedings of the National Academy of Science (PNAS).

5 Oct 2010

Enzo commences clinical trial of Optiquel for chronic non-infectious uveitis

Enzo Biochem, Inc., announced today that, following filing of a investigational new drug (IND) application with the FDA, its Enzo Therapeutics division is commencing a clinical trial of Optiquel™ , the Company's proprietary oral therapeutic for chronic non-infectious uveitis. The trial is designed as a randomized, double-masked, placebo-controlled study with a long-term follow-up and is being conducted by the National Institute of Health's National Eye Institute (NEI).

4 Oct 2010

Life Technologies acquires Ion Torrent for $375 million

Life Technologies Corporation, a provider of innovative life science solutions, today announced that it has completed the previously announced acquisition of Ion Torrent for $375 million in cash and stock. In addition, sellers are entitled to additional consideration upon the achievement of certain milestones.

4 Oct 2010

Advanced BioHealing to present industry experience at 2010 World Stem Cell Summit

Advanced BioHealing, Inc. (ABH), a leader in commercializing the promise of regenerative medicine, announced that Senior Vice President, Dean Tozer and Vice President of Government Affairs and Health Economics, Therésa Dixon will speak on behalf of the Company at the 2010 World Stem Cell Summit, sharing their more than 30 years of combined industry experience with attendees.

4 Oct 2010

Noninvasive embryo assessment technology may improve success rates for in vitro fertilization procedures

Auxogyn, Inc., a privately held medical technology company focused on women's reproductive health, today announced that it acquired an exclusive license from Stanford University to develop a set of products that may allow medical practitioners in the field of assisted reproduction to significantly improve the effectiveness of in vitro fertilization (IVF) procedures.

4 Oct 2010

Biotechnology News and Research

Isogenica, NovaBiotics to accelerate the development of peptide anti-infective technology

Apricus Bio raises over $9.3 million in securities offering

TMNG Global and Scientia Advisors partner to offer strategic consulting services for home health sector

Galapagos honored with 2010 EUROPEAN BIOTECHNICA AWARD

ImmunoCellular Therapeutics to present ICT-107 clinical data at World Stem Cell Summit

EUCODIS Bioscience, evocatal enter alliance to market industrial enzyme products

Genzyme shareholders urged not to take action on unsolicited tender offer from Sanofi-Aventis

Bio-Matrix Scientific Group in discussions to develop adult stem cell repositories

PAREXEL expands presence in Japan with new office in Nagoya

Asterand to supply clinically annotated human biospecimens for The Cancer Genome Atlas project

Researchers call for sustained funding to move HIV vaccine R&D ahead

Evotec enters multiple target drug discovery collaboration with Shionogi

Amgen announces PRIME '203' and '181' Phase 3 trial results

Seattle Genetics to present SGN-75 phase I data at ESMO Congress

CHI submits comments to FDA CDRH 510(k) Working Group Preliminary Report and Recommendations

Terminal metastatic cancer effectively treated in mice

Enzo commences clinical trial of Optiquel for chronic non-infectious uveitis

Life Technologies acquires Ion Torrent for $375 million

Advanced BioHealing to present industry experience at 2010 World Stem Cell Summit

Noninvasive embryo assessment technology may improve success rates for in vitro fertilization procedures

Event guide: 3rd IMPACCT Real World Evidence Summit Europe eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News